Treatment of recurrent ovarian cancer: Increasing options - ''Recurrent'' results

被引：82
作者：
Ozols, RF
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1997年 / 15卷 / 06期
关键词：
D O I：
10.1200/JCO.1997.15.6.2177
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2177 / 2180
页数：4
相关论文
共 28 条
[1]   Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [J].
Alberts, DS ;
Liu, PY ;
Hannigan, EV ;
OToole, R ;
Williams, SD ;
Young, JA ;
Franklin, EW ;
ClarkePearson, DL ;
Malviya, VK ;
DuBeshter, B ;
Adelson, MD ;
Hoskins, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1950-1955
[2]   Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: Activity in platinum-resistant disease [J].
Bajetta, E ;
DiLeo, A ;
Biganzoli, L ;
Mariani, L ;
Cappuzzo, F ;
DiBartolomeo, M ;
Zilembo, N ;
Artale, S ;
Magnani, E ;
Celio, L ;
Buzzoni, R ;
Carnaghi, C .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (09) :2546-2551
[3]  
Bergman AM, 1996, CLIN CANCER RES, V2, P521
[4]   Carboplatin and paclitaxel in ovarian carcinoma: A phase I study of the Gynecologic Oncology Group [J].
Bookman, MA ;
McGuire, WP ;
Kilpatrick, D ;
Keenan, E ;
Hogan, WM ;
Johnson, SW ;
ODwyer, P ;
Rowinsky, E ;
Gallion, HH ;
Ozols, RF .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) :1895-1902
[5]  
CORN BW, 1994, CANCER, V74, P2979, DOI 10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO
[6]  
2-B
[7]   Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: Results of a large European phase II study [J].
Creemers, GJ ;
Bolis, G ;
Gore, M ;
Scarfone, G ;
Lacave, AJ ;
Guastalla, JP ;
Despax, R ;
Favalli, G ;
Kreinberg, R ;
VanBelle, S ;
Hudson, I ;
Verweij, J ;
Huinink, WWT .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (12) :3056-3061
[8]   Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer [J].
Fennelly, D ;
Aghajanian, C ;
Shapiro, F ;
OFlaherty, C ;
McKenzie, M ;
OConnor, C ;
Tong, W ;
Norton, L ;
Spriggs, D .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :187-192
[9]  
HATCH KD, 1991, CANCER, V68, P269, DOI 10.1002/1097-0142(19910715)68:2<269::AID-CNCR2820680209>3.0.CO
[10]  
2-O
123